Synergistic Effect of Colistin Combined with PFK-158 against Colistin-Resistant Enterobacteriaceae

As increasing numbers of colistin-resistant bacteria emerge, new therapies are urgently needed to treat infections caused by these pathogens. The discovery of new combination therapies is one important way to solve such problems. Here, we report that the antitumor drug PFK-158 and its analogs PFK-01...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Zhang, Youwen, Wang, Xiukun, Li, Xue, Dong, Limin, Hu, Xinxin, Nie, Tongying, Lu, Yun, Lu, Xi, Pang, Jing, Li, Guoqing, Yang, Xinyi, Li, Congran, You, Xuefu
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591609/
https://ncbi.nlm.nih.gov/pubmed/30988150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00271-19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados